Streetbeat News

Stock Prices

ICU

SeaStar Medical Holding Corporation (NASDAQ:ICU) has treated its first pediatric patient in a commercial setting with its FDA-approved QUELIMMUNE™ therapeutic device for acute kidney injury (AKI). This milestone meets the FDA's deadline for patient treatments by August 20, 2024.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 12:36 pm

TIRX

TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) has regained compliance with Nasdaq's periodic filing requirement after submitting its annual report on Form 20-F for the period ended October 31, 2023.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 12:35 pm

ITB

PHM

PKB

PulteGroup, Inc. (NYSE:PHM) reported strong Q2 FY24 results with revenue of $4.60 billion, beating expectations. Home sale revenues rose 10% Y/Y, and GAAP EPS of 3.83 surpassed the consensus of 3.26. Despite a decline in net new orders, the dollar value of these orders increased. The company repurchased 2.8 million shares and announced a CFO transition. Investors can gain exposure via IShares U.S. Home Construction ETF (BATS:ITB) and Invesco Building & Construction ETF (NYSE:PKB).

Portfolio Pulse from Lekha Gupta

July 23, 2024 | 12:33 pm

GATX

GATX (NYSE:GATX) reported Q2 earnings of $1.43 per share, missing the analyst estimate of $1.77 by 19.21%. However, sales of $386.70M beat the estimate of $385.45M. Earnings decreased by 17.34% YoY, while sales increased by 12.67% YoY.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 12:32 pm

GM

General Motors (NYSE: GM) reported strong Q2 2024 earnings, with revenue and EPS beating analyst estimates. Despite challenges in EV adoption and the Chinese market, GM raised its annual outlook. The company is pausing production of its Cruise Origin autonomous vehicle and expects higher commodity costs in the second half of the year.

Portfolio Pulse from Anusuya Lahiri

July 23, 2024 | 12:25 pm

KO

Coca-Cola (NYSE:KO) reported better-than-expected Q2 FY24 earnings, with a 3% YoY sales growth to $12.4 billion, beating the $11.753 billion consensus estimate. The company raised its FY24 revenue and EPS growth outlooks, leading to a 1.65% premarket share price increase.

Portfolio Pulse from Shivani Kumaresan

July 23, 2024 | 12:23 pm

PGEN

Precigen, Inc. (NASDAQ:PGEN) has appointed Phil Tennant as the chief commercial officer to spearhead the commercial readiness and pre-launch activities for PRGN-2012, a potential first-in-class gene therapy for recurrent respiratory papillomatosis (RRP).

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 12:18 pm

AAPL

Apple Inc. (NASDAQ:AAPL) plans to integrate its A18 chip into upcoming entry-level iPhones and iPads to enable Apple Intelligence AI features. This move aims to extend AI capabilities across all new iPhone 16 models and potentially new HomePod and iPad models.

Portfolio Pulse from Rounak Jain

July 23, 2024 | 12:16 pm

CMCSA

DIS

IYZ

NFLX

VOX

Comcast Corp. (NASDAQ:CMCSA) is betting on the 2024 Paris Olympics to boost its streaming service, Peacock. The company has invested heavily in exclusive Olympic content to attract and retain viewers, positioning itself against competitors like Netflix (NASDAQ:NFLX) and Disney+ (NYSE:DIS). Despite past setbacks, Comcast continues to invest in original content and sports to grow Peacock's subscriber base.

Portfolio Pulse from Shivani Kumaresan

July 23, 2024 | 12:16 pm

BNGO

Bionano Genomics (NASDAQ: BNGO) announced the publication of a multi-site study comparing optical genome mapping (OGM) to traditional cytogenetic methods for detecting structural variants in multiple myeloma. The study highlights OGM's potential advantages over existing methods like FISH, CMA, and KT, particularly in identifying complex gene rearrangements in plasma cell neoplasms.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 12:15 pm